Concepedia

Armen Asatryan

AA

Statistics

Publications

26

Citations

1.9K

H-Index

20

Active since

2015

Affiliations

AbbVie (United States)(Current)

Texas Liver Institute

The University of Texas Health Science Center at San Antonio

Bakersfield College

Hôpital Beaujon

Armen Asatryan is an author at AbbVie (United States) specializing in medicine, viral hepatitis, and hepatitis.

Top concepts

Publications per year

2015–2020

26

Publications

26

Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

Stefan Zeuzem, Graham R. Foster, Stanley Wang et al. · New England Journal of Medicine · 2018 · 426 citations · Full text

Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1–6 without cirrhosis

Paul Y. Kwo, Fred Poordad, Armen Asatryan et al. · Journal of Hepatology · 2017 · 296 citations · Full text

, , +9

Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct‐acting antiviral treatment

Fred Poordad, Franco Felizarta, Armen Asatryan et al. · Hepatology · 2017 · 200 citations · Full text

Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct‐acting antiviral treatment failure

Fred Poordad, Stanislas Pol, Armen Asatryan et al. · Hepatology · 2017 · 136 citations · Full text

Pharmacokinetics, Safety and Tolerability of ABT-494, a Novel Selective JAK 1 Inhibitor, in Healthy Volunteers and Subjects with Rheumatoid Arthritis

Mohamed‐Eslam F. Mohamed, Heidi S. Camp, Ping Jiang et al. · Clinical Pharmacokinetics · 2016 · 114 citations

, , +10

1–5 of 26